Skip to main content

Posts

Showing posts with the label Oncology

Have Cancer Treatment Costs Grown Beyond 'Sustainability?'

Many factors drive the increasing cost of cancer care.  Sophisticated, targeted drugs are expensive to develop, test and market.  Desperate patients demand them.  Other therapies - proton beam accelerators, e.g., though engineering marvels, are capital and labor intensive.  To the mix, add a healthcare system that very rarely measures costs against benefits and says 'No. We're not doing that.' Chicago Tribune :  "Cancer cost "becoming unsustainable" in rich nations." "...a radical shift in thinking is needed to ensure fairer access to medicines and address tricky questions like balancing extra months of life for patients against costs of a new drug, technology or care plan, (oncology experts) said." "The cancer community needs to take responsibility and not accept a sub-standard evidence base and an ethos of very small benefit at whatever cost," said a report commissioned by the Lancet Oncology medical journal on the costs of can...

Cancer Commons Taps the Crowd For Treatment Advice

From Springwise: a web app that taps medical crowds for personalized cancer treatment . " California-based Cancer Commons was founded by a cancer survivor who believes he would not have found the experimental therapies that saved him if not for personal connections at the US National Cancer Institute, according to a CBC News report. Accordingly, the free “open science” initiative hopes to help others succeed as well by creating new ways of finding individually tailored cancer information online. Beginning with melanoma, Cancer Commons is being developed one cancer at a time in partnership with leading professional and patient advocacy organizations, pharmaceutical companies, medical centers, and health informatics companies. At the core of each resulting “commons” is a curated Molecular Disease Model (MDM) that lists the known molecular subtypes of that cancer and then links to the relevant pathways, diagnostic tests, approved and experimental (targeted) therapies, and clinica...

Are Single-Specialty ACOs In Your Future?

AIS's Health Business Daily: "US Oncology May Go National With Private-Sector Accountable Care Organization." "Leonard Kalman, M.D., who is one of several medical directors for the huge for-profit oncology practice-management firm and chairman of the board of managers of Miami-based Advanced Medical Specialties, says that he thinks US Oncology-affiliated practices as a whole, including his, are interested in exploring such commercial ACO-like ventures. In fact, he says, a major hospital in Miami has approached his 40-physician practice about handling cancer care in such a way. “Our ACO partner is a dominant hospital system where we put basically all of our patients,” he says, declining to name it. "When cancer becomes the primary diagnosis, the oncologist basically handles the patient’s primary care, Kalman explains. “Remember, the majority of an oncology patient’s care is cancer care,” he says. So while ACO patients may require occasional care from other so...

World Class Oncology Programs

From the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (via Becker's Hospital Review) here are seven keys to developing a world class oncology program . How will you know when you've arrived?  Wondering what a world class oncology program looks like?  Here's Becker's list of 30 Hospitals With Great Oncology Programs.  You're probably not on that list, but it doesn't mean you can't be.   What's holding you back? 

Second Opinion Program Aims to Improve Cancer Care

From Angela Mass, writing for AIS's Health Business Daily : "Recognizing the importance of getting an accurate cancer diagnosis from the beginning, a handful of companies are taking advantage of a program that gives a second opinion to people who have a cancer diagnosis. Offered through Partners HealthCare System, Inc.’s Center for Connected Health, Partners Online Specialty Consultations is a website that offers second opinions from specialists at a Harvard Medical School-affiliated hospital." Supermarket chain Hannaford Bros. Co is an early client, motivated, in part, by discovering that local physicians were following National Comprehensive Cancer Network (NCCN) guidelines only 30% of the time. According to Bill Sullivan, principal consultant for Specialty Pharmacy Solutions LLC, “...There is a direct corollary with cost containment (e.g., not wasting dollars on an ineffective protocol). Patients would be better served by being prescribed the presumed most effica...

Radiation Safety and Trust As A Business Strategy

Dr. Matthew Katz, M.D. commented on yesterday's post here on Health Care Strategist , positing that cancer registry statistics place the official rate of radiation injury closer to 0.1% - far lower than the Times' 5% estimate. I'm tempted to split the difference. A 5% error rate may be too high, but given the pervasive under-reporting of medical errors, 0.1% is almost certainly too low. Dr. Katz is right about one thing though: the greatest harm of all would occur if frightened patients avoid potentially life-saving care. And therein lies today's headline: it's all about trust. Today The NY Times ' Walt Bogdanich continues his series on radiation safety with an article spotlighting Intensity Modulated Radiation Therapy (I.M.R.T.), an expensive, complicated technology that's lifesaving in the right hands, dangerous in others. Full disclosure on my part: I'm not a Radiation Safety Officer nor do I have those magical initials "M.D." after m...

"1 In 20 Radiation Therapy Patients Will Suffer Injuries."

From the NY Times, that's an estimate from a radiation oncologist and leading authority in the treatment of radiation injuries. 1 in 20. 5 out of every 100. "Most are normal complications from radiation, not mistakes... But in some cases the line between the two is uncertain..." . "My suspicion is that maybe half of the accidents we don't know about..." says another expert. What's the true rate of error-caused injury from radiation therapy? Since radiation has inevitable side effects, maybe it's not as bad as 1 in 20. But injuries are said to be under-reported so maybe it's worse. Let's say the two adjustments cancel each other out and 1 in 20 is close to the real rate. Name another industry that injures or kills five percent of its customers. This being health care, mistakes leading to injury are blamed on everything from balky computer software to staffing shortages to something called a "wide open multileaf collimator." A...

Minimally Invasive Prostate Surgery: Not Always Better

Today's NY Times reports on a JAMA article comparing outcomes from various types of prostate surgeries . The study found that increasingly-popular minimally invasive techniques have more of the complications men worry most about: impotence and incontinence. “People intuitively think that a minimally invasive approach has fewer complications, even in the absence of data,” said Dr. Jim C. Hu, the study’s lead author, who is director of urologic robotic and minimally invasive surgery at Brigham and Women’s Hospital in Boston. “Men who were well educated and had higher incomes were actually more likely to embrace this approach, often due to aggressive marketing by hospitals that had spent $1.5 million to acquire the robots . I think the technology has been oversold.” ... Dr. Peter Scardino, chief of surgery at Memorial Sloan-Kettering, said the study was important because it reported on data that did not come just from one medical center or one region. “At the end of the day,” Dr. Sca...

Study Doubts Value Of Screening For Prostate Cancer

Studies reported in this week's New England Journal of Medicine question the value of routine screening tests for prostate cancer. Today's New York Times puts the data in perspective : "Dr. Peter B. Bach, a physician and epidemiologist at Memorial Sloan-Kettering Cancer Center, says one way to think of the data is to suppose (a patient) has a PSA test today. It leads to a biopsy that reveals he has prostate cancer, and he is treated for it. There is a one in 50 chance that, in 2019 or later, he will be spared death from a cancer that would otherwise have killed him. And there is a 49 in 50 chance that he will have been treated unnecessarily for a cancer that was never a threat to his life. " Conclusion: for the occasional life saved by a PSA test, there is a substantial risk of over-diagnosis and over-treatment. So much for adding "free PSA tests" to your list of "community benefits." And maybe health care planners should re-examine those rosy ...